AR011517A1 - Analogos proteicos relacionados con la hormona paratiroides - Google Patents
Analogos proteicos relacionados con la hormona paratiroidesInfo
- Publication number
- AR011517A1 AR011517A1 ARP980100058A ARP980100058A AR011517A1 AR 011517 A1 AR011517 A1 AR 011517A1 AR P980100058 A ARP980100058 A AR P980100058A AR P980100058 A ARP980100058 A AR P980100058A AR 011517 A1 AR011517 A1 AR 011517A1
- Authority
- AR
- Argentina
- Prior art keywords
- acc
- cha
- leu
- phe
- aib
- Prior art date
Links
- 102000003982 Parathyroid hormone Human genes 0.000 title abstract 2
- 108090000445 Parathyroid hormone Proteins 0.000 title abstract 2
- 239000000199 parathyroid hormone Substances 0.000 title abstract 2
- 229960001319 parathyroid hormone Drugs 0.000 title abstract 2
- 102000004169 proteins and genes Human genes 0.000 title abstract 2
- 108090000623 proteins and genes Proteins 0.000 title abstract 2
- 229910052736 halogen Inorganic materials 0.000 abstract 4
- 150000002367 halogens Chemical class 0.000 abstract 4
- 125000004400 (C1-C12) alkyl group Chemical group 0.000 abstract 2
- 125000003342 alkenyl group Chemical group 0.000 abstract 2
- 125000002768 hydroxyalkyl group Chemical group 0.000 abstract 2
- 125000001326 naphthylalkyl group Chemical group 0.000 abstract 2
- 125000003884 phenylalkyl group Chemical group 0.000 abstract 2
- 125000004642 (C1-C12) alkoxy group Chemical group 0.000 abstract 1
- ODKSFYDXXFIFQN-UHFFFAOYSA-N Arginine Chemical compound OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 abstract 1
- 239000004215 Carbon black (E152) Substances 0.000 abstract 1
- 101000909637 Homo sapiens Transcription factor COE1 Proteins 0.000 abstract 1
- 102100024207 Transcription factor COE1 Human genes 0.000 abstract 1
- 125000003917 carbamoyl group Chemical group [H]N([H])C(*)=O 0.000 abstract 1
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 abstract 1
- 229930195733 hydrocarbon Natural products 0.000 abstract 1
- 150000002430 hydrocarbons Chemical class 0.000 abstract 1
- 125000005020 hydroxyalkenyl group Chemical group 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
- C07K14/635—Parathyroid hormone, i.e. parathormone; Parathyroid hormone-related peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/18—Drugs for disorders of the endocrine system of the parathyroid hormones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Endocrinology (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Physical Education & Sports Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Molecular Biology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Genetics & Genomics (AREA)
- Toxicology (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Rheumatology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Diabetes (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
Abstract
Análogos proteicos relacionados con la hormona paratiroides, que comprende la formula (I), donde: A1 es Ser, Ala o Dap; A3 es Ser, Thr o Aib; A5 es Leu,Nle, Ile, Cha, Beta-Nal, Trp, Pal, Acc, Phe o p-X-Phe, donde X es OH, un halogeno o CH3;A 7 es Leu, Nle, Ile, Cha, Beta-Nal, Trp, Pal, Acc, Phe o p-X-Phe, donde X es OH, un halogeno o CH3; A8 es Met, Nva, Leu, Val, Ile, Cha, Acc, o Nle; A11 es Leu, Nle, Ile, Cha, Beta-Nal, Trp, Pal, Acc, Phe o p-X-Phe, dondeX es OH, un halogeno, o CH3;A1 2 es Gly, Acc, o Aib; A15 es Leu, Nle, Ile, Cha, Beta-Nal, Trp, Pal, Acc, Phe o p-X-Phe, donde X es OH, un halogeno o CH3; A16es Ser, Asn, Ala o Aib; A18 es Met, Nva, Leu, Val, Ile, Nle, Acc, Cha o Aib; A19 es Glu o Aib; A21 es Val, Acc, Cha oMet ; A22 es Acc o Glu; A23 es Trp,Acc, o Cha; A24 es Leu, Acc, o Cha; A27 es Lys, Aib, Leu, hArg, Gln, Acc, o Cha; A28 es Leu, Acc, o Cha; A29 es Glu, Acc, o Aib; A30 es Aps, o Lys; A31es Val, Leu, Nle, Acc, Cha o está suprimido; A32 es His oestá s uprimido; A33 es Ans o está suprimido; A34 es Phe, Tyr, Amp, Aib o está suprimido; cada unode R1 o R2 es, en forma independiente, H, alquilo C1-12, alquenilo, C2-12, fenilalquilo C7-20, naftilalquilo C11-20, hidroxialquilo C1-12,hidroxialquil oC2-12; hidroxifenilalquilo C7-20; o hidroxinaftilalquilo C11-20; o uno y solamente uno de R1 y R2 es COE1, donde E1 es alquilo C1-12, alquenilo C2-12,fenialquilo C7-20, naftilalquilo C11-20, hidroxialquilo C1-12,hidroxialquenilo C2-12, hidro xifenilalquilo C7-20, hidroxinaftilalquilo C11-20; y R3 es OH, NH2,alcoxi C1-12, o NH- Y - CH2 -Z, donde Y, es una porcion de hidrocarburo C1-12; y Z es H, OH, CO2H, o CONH2; siempre y cuando al menos uno de A5, A7,A8, A11,A12, A15, A18, A21, A22, A23, A24, A27, A28, A29, y A31 sea Acc; o una sal farmacéuticamente aceptable de los mismos.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US08/779,768 US5969095A (en) | 1995-07-13 | 1997-01-07 | Analogs of parathyroid hormone |
US08/813,534 US5955574A (en) | 1995-07-13 | 1997-03-07 | Analogs of parathyroid hormone |
Publications (1)
Publication Number | Publication Date |
---|---|
AR011517A1 true AR011517A1 (es) | 2000-08-30 |
Family
ID=27119618
Family Applications (3)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ARP980100058A AR011517A1 (es) | 1997-01-07 | 1998-01-06 | Analogos proteicos relacionados con la hormona paratiroides |
ARP030100515A AR038552A2 (es) | 1997-01-07 | 2003-02-17 | Analogos proteicos relacionados con la hormona paratiroides |
ARP060100191A AR051906A2 (es) | 1997-01-07 | 2006-01-18 | Analogos proteicos relacionados con la hormona paratiroides |
Family Applications After (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ARP030100515A AR038552A2 (es) | 1997-01-07 | 2003-02-17 | Analogos proteicos relacionados con la hormona paratiroides |
ARP060100191A AR051906A2 (es) | 1997-01-07 | 2006-01-18 | Analogos proteicos relacionados con la hormona paratiroides |
Country Status (24)
Country | Link |
---|---|
US (1) | US5955574A (es) |
EP (3) | EP1645566B1 (es) |
JP (1) | JP3963482B2 (es) |
KR (2) | KR100497709B1 (es) |
CN (1) | CN1137898C (es) |
AR (3) | AR011517A1 (es) |
AT (2) | ATE471342T1 (es) |
AU (1) | AU741584B2 (es) |
BR (1) | BR9714200A (es) |
CA (1) | CA2276614C (es) |
CZ (2) | CZ301497B6 (es) |
DE (2) | DE69735603T2 (es) |
DK (2) | DK1645566T3 (es) |
ES (2) | ES2258286T3 (es) |
HK (1) | HK1026215A1 (es) |
HU (1) | HUP9904596A3 (es) |
IL (1) | IL130794A0 (es) |
NO (1) | NO993341L (es) |
NZ (1) | NZ336610A (es) |
PL (1) | PL191898B1 (es) |
PT (2) | PT1645566E (es) |
RU (1) | RU2198182C2 (es) |
SI (2) | SI0948541T1 (es) |
WO (1) | WO1998030590A2 (es) |
Families Citing this family (29)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7410948B2 (en) * | 1995-07-13 | 2008-08-12 | Societe De Conseils De Recherches Et D'applications Scientifiques, Sas | Analogs of parathyroid hormone |
US6544949B1 (en) * | 1995-07-13 | 2003-04-08 | Societe De Conseils De Recherches Et D'applications Scientifiques, S.A.S. | Analogs of parathyroid hormone |
JP2002509854A (ja) | 1997-09-09 | 2002-04-02 | エフ.ホフマン−ラ ロシュ アーゲー | PTHrP類似体を使用する骨折治癒 |
HUP0300891A2 (hu) * | 1998-05-05 | 2003-07-28 | Beth Israel Deaconess Medical Center, Inc. | PTH2 receptor szelektív vegyületek és alkalmazásuk gyógyszerkészítmények előállÍtására |
DE69941708D1 (de) * | 1998-07-20 | 2010-01-07 | Ipsen Pharma | Pacap-peptidanaloga |
US6660843B1 (en) † | 1998-10-23 | 2003-12-09 | Amgen Inc. | Modified peptides as therapeutic agents |
WO2001060862A1 (en) | 2000-02-18 | 2001-08-23 | Dabur Research Foundation | Vasoactive intestinal peptide analogs |
US6756480B2 (en) * | 2000-04-27 | 2004-06-29 | Amgen Inc. | Modulators of receptors for parathyroid hormone and parathyroid hormone-related protein |
US20050124537A1 (en) * | 2000-04-27 | 2005-06-09 | Amgen Inc. | Modulators of receptors for parathyroid hormone and parathyroid hormone-related protein |
MXPA03011027A (es) | 2001-06-01 | 2004-03-19 | Novartis Ag | Administracion oral de hormona paratiroides y calcitonina. |
CA2454275C (en) | 2001-07-23 | 2012-10-23 | The General Hospital Corporation | Conformationally constrained parathyroid hormone (pth) analogs |
KR20060056975A (ko) * | 2003-08-06 | 2006-05-25 | 로디아 인코포레이티드 | 뼈 성장 촉진방법 |
AU2006315132A1 (en) | 2005-11-10 | 2007-05-24 | Board Of Control Of Michigan Technological University | Black bear parathyroid hormone and methods of using black bear parathyroid hormone |
US7803770B2 (en) | 2006-10-03 | 2010-09-28 | Radius Health, Inc. | Method of treating osteoporosis comprising administration of PTHrP analog |
USRE49444E1 (en) | 2006-10-03 | 2023-03-07 | Radius Health, Inc. | Method of treating osteoporosis comprising administration of PTHrP analog |
CN102274492B (zh) * | 2006-10-03 | 2014-11-26 | 半径健康公司 | 骨合成代谢蛋白质的药物递送方法 |
WO2008048784A1 (en) * | 2006-10-13 | 2008-04-24 | Eli Lilly And Company | Pegylated pth as pth receptor modulators and uses thereof |
EP2187902B1 (en) | 2007-08-01 | 2013-04-17 | The General Hospital Corporation | Screening methods using g-protein coupled receptors and related compositions |
US8563513B2 (en) | 2009-03-27 | 2013-10-22 | Van Andel Research Institute | Parathyroid hormone peptides and parathyroid hormone-related protein peptides and methods of use |
EP2509996A1 (en) | 2009-12-07 | 2012-10-17 | Michigan Technological University | Black bear parathyroid hormone and methods of using black bear parathyroid hormone |
MX342898B (es) | 2010-05-12 | 2016-10-18 | Radius Health Inc * | Regimen terapéutico de la sal de diclorhidrato del (r) -6-(2-(etil (4-2(etilamino) etil) bencil) amino)-4-metoxifenil)-5, 6,7,8-tetrahidronaftaleno-2-ol. |
US9492508B2 (en) | 2010-05-13 | 2016-11-15 | The General Hospital Corporation | Parathyroid hormone analogs and uses thereof |
JP5965909B2 (ja) | 2010-09-28 | 2016-08-10 | ラジウス ヘルス,インコーポレイテッド | 選択的アンドロゲン受容体モジュレーター |
SG11201708858WA (en) | 2015-04-29 | 2017-11-29 | Radius Pharmaceuticals Inc | Methods of treating cancer |
CN108025042A (zh) * | 2015-07-06 | 2018-05-11 | 董正欣 | PTHrP类似物的新型制剂 |
SG11201811225RA (en) | 2016-06-22 | 2019-01-30 | Radius Health Inc | Ar+ breast cancer treatment methods |
JP7481115B2 (ja) | 2017-01-05 | 2024-05-10 | ラジウス ファーマシューティカルズ,インコーポレイテッド | Rad1901-2hclの多形性形態 |
US10996208B2 (en) | 2017-04-28 | 2021-05-04 | Radius Health, Inc. | Abaloparatide formulations and methods of testing, storing, modifying, and using same |
AU2019297421B2 (en) | 2018-07-04 | 2024-08-29 | Radius Pharmaceuticals, Inc. | Polymorphic forms of RAD 1901-2HCL |
Family Cites Families (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3773919A (en) | 1969-10-23 | 1973-11-20 | Du Pont | Polylactide-drug mixtures |
IE52535B1 (en) | 1981-02-16 | 1987-12-09 | Ici Plc | Continuous release pharmaceutical compositions |
FR2550204B1 (fr) * | 1983-08-05 | 1987-11-13 | Toyo Jozo Kk | Derives peptidiques de (nle8,nle1b, tyr34)-h-pth |
EP0293158A3 (en) * | 1987-05-26 | 1990-05-09 | Merck & Co. Inc. | Parathyroid hormone antagonists |
EP0411096A1 (de) * | 1989-02-23 | 1991-02-06 | Gesellschaft für Biotechnologische Forschung mbH (GBF) | Pth-varianten kodierende dna-sequenzen, pth-varianten, expressionsvektor, bakterieller wirt, verwendung und therapeutische zusammensetzung |
CA2040264A1 (en) * | 1990-04-12 | 1991-10-13 | Tatsuhiko Kanmera | Parathyroid hormone antagonists |
JPH0532696A (ja) * | 1990-09-28 | 1993-02-09 | Takeda Chem Ind Ltd | 副甲状腺ホルモン誘導体 |
WO1993006846A1 (en) * | 1991-10-10 | 1993-04-15 | Pang Peter K T | Parathyroid hormone analogues and use in osteoporosis treatment |
US5434246A (en) * | 1992-03-19 | 1995-07-18 | Takeda Chemical Industries, Ltd. | Parathyroid hormone derivatives |
CA2098639A1 (en) * | 1992-06-19 | 1993-12-20 | K. Anne Kronis | Bone stimulating, non-vasoactive parathyroid hormone variants |
US5821225A (en) * | 1992-07-14 | 1998-10-13 | Syntex (U.S.A.) Inc. | Method for the treatment of corticosteroid induced osteopenia comprising administration of modified PTH or PTHrp |
US5589452A (en) * | 1992-07-14 | 1996-12-31 | Syntex (U.S.A.) Inc. | Analogs of parathyroid hormone and parathyroid hormone related peptide: synthesis and use for the treatment of osteoporosis |
AU672790B2 (en) * | 1992-07-15 | 1996-10-17 | Novartis Ag | Variants of parathyroid hormone and its fragments |
NZ261250A (en) | 1993-01-06 | 1997-08-22 | Kinerton Ltd | Ionic conjugates of polypeptides |
CN1070500C (zh) * | 1993-07-13 | 2001-09-05 | 森德克斯(美国)股份有限公司 | 甲状旁腺激素类似物和甲状旁腺激素相关肽:合成和治疗骨质疏松症的用途 |
WO1996019246A1 (en) * | 1994-12-19 | 1996-06-27 | Beth Israel Hospital Association | Continuous low-dose administration of parathyroid hormone or its agonist |
CA2178894A1 (en) * | 1995-06-15 | 1996-12-16 | Tsunehiko Fukuda | Parathyroid hormone derivatives and their use |
US5723577A (en) * | 1995-07-13 | 1998-03-03 | Biomeasure Inc. | Analogs of parathyroid hormone |
-
1997
- 1997-03-07 US US08/813,534 patent/US5955574A/en not_active Expired - Lifetime
- 1997-12-08 KR KR10-1999-7006165A patent/KR100497709B1/ko not_active IP Right Cessation
- 1997-12-08 SI SI9730730T patent/SI0948541T1/sl unknown
- 1997-12-08 BR BR9714200-0A patent/BR9714200A/pt not_active IP Right Cessation
- 1997-12-08 NZ NZ336610A patent/NZ336610A/en not_active IP Right Cessation
- 1997-12-08 EP EP05026436A patent/EP1645566B1/en not_active Expired - Lifetime
- 1997-12-08 ES ES97951595T patent/ES2258286T3/es not_active Expired - Lifetime
- 1997-12-08 CZ CZ20050594A patent/CZ301497B6/cs not_active IP Right Cessation
- 1997-12-08 AU AU55199/98A patent/AU741584B2/en not_active Ceased
- 1997-12-08 DK DK05026436.5T patent/DK1645566T3/da active
- 1997-12-08 DK DK97951595T patent/DK0948541T3/da active
- 1997-12-08 PT PT05026436T patent/PT1645566E/pt unknown
- 1997-12-08 SI SI9730795T patent/SI1645566T1/sl unknown
- 1997-12-08 EP EP97951595A patent/EP0948541B1/en not_active Expired - Lifetime
- 1997-12-08 RU RU99117145/04A patent/RU2198182C2/ru not_active IP Right Cessation
- 1997-12-08 AT AT05026436T patent/ATE471342T1/de active
- 1997-12-08 DE DE69735603T patent/DE69735603T2/de not_active Expired - Lifetime
- 1997-12-08 DE DE69739912T patent/DE69739912D1/de not_active Expired - Lifetime
- 1997-12-08 PL PL334438A patent/PL191898B1/pl not_active IP Right Cessation
- 1997-12-08 JP JP53086598A patent/JP3963482B2/ja not_active Expired - Fee Related
- 1997-12-08 IL IL13079497A patent/IL130794A0/xx not_active IP Right Cessation
- 1997-12-08 ES ES05026436T patent/ES2347154T3/es not_active Expired - Lifetime
- 1997-12-08 AT AT97951595T patent/ATE321784T1/de active
- 1997-12-08 CN CNB971819157A patent/CN1137898C/zh not_active Expired - Fee Related
- 1997-12-08 EP EP10156965A patent/EP2206725A1/en not_active Withdrawn
- 1997-12-08 CZ CZ0239899A patent/CZ298937B6/cs not_active IP Right Cessation
- 1997-12-08 CA CA002276614A patent/CA2276614C/en not_active Expired - Fee Related
- 1997-12-08 WO PCT/US1997/022498 patent/WO1998030590A2/en active IP Right Grant
- 1997-12-08 PT PT97951595T patent/PT948541E/pt unknown
- 1997-12-08 KR KR1020057003295A patent/KR100699422B1/ko not_active IP Right Cessation
- 1997-12-08 HU HU9904596A patent/HUP9904596A3/hu unknown
-
1998
- 1998-01-06 AR ARP980100058A patent/AR011517A1/es active IP Right Grant
-
1999
- 1999-07-06 NO NO993341A patent/NO993341L/no not_active Application Discontinuation
-
2000
- 2000-09-01 HK HK00105467A patent/HK1026215A1/xx not_active IP Right Cessation
-
2003
- 2003-02-17 AR ARP030100515A patent/AR038552A2/es active IP Right Grant
-
2006
- 2006-01-18 AR ARP060100191A patent/AR051906A2/es unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AR011517A1 (es) | Analogos proteicos relacionados con la hormona paratiroides | |
AR019131A1 (es) | Analogos de polipeptidos pituitarios que activan la adenilato ciclasa, una composicion farmaceutica que los comprende, y el uso de dichos peptidos para lamanufactura de un medicamento | |
US7410948B2 (en) | Analogs of parathyroid hormone | |
RU99117145A (ru) | Аналоги гормона паращитовидной железы | |
US6544949B1 (en) | Analogs of parathyroid hormone | |
TW200626613A (en) | Analogues of GLP-1 | |
IL122837A (en) | Analogs of parathyroid hormone | |
CA2292846A1 (en) | Lh-rh peptide analogues, their uses and pharmaceutical compositions containing them | |
AU589674B2 (en) | GRF analogs | |
AR040955A1 (es) | Analogos de ghrelina | |
ATE384743T1 (de) | Aminoterminal modifizierte parathyroidhormon (pth) analoge | |
PT96135A (pt) | Processo para a preparacao de analogos peptido de somatostatina tendo treonina na sexta posicao | |
SE9302124D0 (sv) | Biologically active vasopressin analogues | |
KR920014777A (ko) | 치환된1,2,3,4-테트라하이드로사이클로펜트[b]인돌 1,2,3,3a,4,8a-헥사하이드로사이클로펜트[b]인돌 및 관련 화합물, 이의 중간체 및 제조방법 및 약제로서의 이의용도 | |
ATE203410T1 (de) | Hepatom-behandlung mit somatostatin-analogen | |
PE20061419A1 (es) | Agonistas del receptor (vpac2) de peptido activador de adenilato ciclasa hipofisaria (pacap) | |
ES8701784A1 (es) | Un procedimiento para preparar un peptido ciclico con acti- vidad antagonista de vasopresina | |
BR9812404A (pt) | Combinação de um antagonista de endotelina, preparação farmacêutica, processo para preparar uma preparação farmacêutica, e , uso de uma combinação de um bloqueador de beta receptor e de um antagonista de endotelina | |
KR840007566A (ko) | 펩티드의 제조방법 | |
NZ335879A (en) | Somatostatin antagonist peptides having a D-amino acid at the second residue | |
ES8707740A1 (es) | Un procedimiento para preparar octapeptidos ciclicos | |
CA2226177A1 (en) | Analogs of parathyroid hormone | |
DK0737691T3 (da) | Bombesinanaloger | |
EP0234935A3 (en) | Vasopressin compounds | |
Rosenblatt et al. | Modification of the arginines in parathyroid hormone: effect on biological activity |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG | Grant, registration |